Skip to main content

Charcot-Marie-Tooth Disease clinical trials at UC Davis

1 research study open to eligible people

Showing trials for
  • Are you living with Charcot-Marie-Tooth Type 1A?

    β€œThe PREMIER study is now enrolling subjects to test a new investigational treatment for CMT1A!”

    open to eligible people ages 16-65

    The purpose of this study is to determine whether PXT3003 is effective and safe in the treatment of Charcot-Marie-Tooth disease - Type 1A. This double-blind study will assess in parallel groups 1 dose of PXT3003 compared to Placebo in CMT1A patients treated for 15 months.

    Sacramento, California and other locations

Last updated: